MOLINA HEALTHCARE, INC. — Annual Report FY2026
Quality Scores
AI Summary
Molina Healthcare (MOH) exemplifies a dramatic corporate turnaround, transitioning from near-insolvency in 2017 to a highly efficient Medicaid and Medicare specialist. Following the 2017 restructuring, the company pivoted from aggressive scale-at-all-costs to margin discipline, resulting in an explosion of earnings power. Revenue has scaled from approximately $4.3B in 2019 to $45.4B by 2025, representing a significant expansion through organic growth and strategic acquisitions like Magellan Complete Care and AgeWell. While net income shows some volatility in recent quarters, the long-term…
Key Changes
The company has undergone a massive evolution from a struggling Medicaid-only player to a diversified, multi-state managed care powerhouse. Between 2017 and 2019, the firm underwent a radical cost-restructuring phase, shedding low-margin contracts and optimizing claims processing. Since 2020, the focus has shifted to inorganic growth, aggressively acquiring state-specific health plans to scale the top line from $19B to over $45B. The product portfolio has expanded to include higher-complexity D-SNP (Dual Eligible) programs and Marketplace plans, reducing reliance on pure Medicaid. This pivot has successfully moved the company up the value chain toward more sophisticated risk-management profiles. Current evolution focuses on technological integration to manage medical loss ratios (MLR)…
Management Commentary
The current leadership team is credited with one of the most successful turnarounds in the healthcare services industry. Under Joe Zubretsky's 'Molina Strategy,' management shifted focus toward margin expansion, rigorous cost control, and surgical bidding for state contracts. Transparency has improved significantly since the 2017 management purge; however, the 2025 earnings miss indicates potential headwinds in managing the medical cost trend. Management's ability to navigate the 'Medicaid Redetermination' process has been the central theme of recent calls. Their execution skill in standardizing the 'Molina Way' across acquired entities remains their strongest qualitative asset.
Financial Highlights
Molina's financial narrative is bifurcated into pre-2018 distress and post-2018 efficiency. The company achieved a massive turnaround in operating margins, which moved from negative territory in 2017 to a peak of $1.71B in operating income by 2024. Revenue CAGR over the last five years is exceptionally high, fueled by the expansion of Medicaid contracts and the 'Molina Strategy' of operational excellence. Despite a dip in 2025 net income to $472M, the historical pattern suggests this is a byproduct of medical loss ratio (MLR) fluctuations rather than structural decay. Asset turnover remains high, and the ROE has historically outperformed the broader insurance sector during the 2020-2024 period.
Major Opportunities
- Stellar revenue growth since 2020
- Successful turnaround from 2017 losses
- High ROE consistently above 25% (pre-2025)
Major Risks
- Sharp decline in net income for FY2025
- Negative operating cash flow in 2025
- Heavy reliance on government Medicaid reimbursement rates
Unlock the full report
Full 20+ sections, charts, AI chat with the report, and PDF export are available with Premium.